Our study with mouse colon cancer cell lines also clearly showed that overexpression of SOX2 led to increased expression of mesenchymal markers (vimentin and N-cadherin) and EMT-inducing transcription factors (e.g., TWIST1), supporting its role in promoting EMT in colon cancer. The gene discussed is SOX2; the disease is malignant colon neoplasm.